跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FAPI-04
首页
药物
FAPI-04
FAPI-04
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
一种靶向成纤维细胞激活蛋白的二聚体MR探针的制备方法
申请人: 广东药科大学附属第一医院
优先权: 2023
CN
Preparation method of MR probe targeting fibroblast activation protein
申请人: THE FIRST AFFILIATED HOSPITAL OF GUANGDONG PHARMACEUTICAL UNIV
优先权: 2023
CN
Preparation method of targeted fibroblast activation protein MR liposome probe
申请人: FIRST HOSPITAL LANZHOU UNIV
优先权: 2024
CN
Application of FAP + myofibroblast as target spot in preparation of medicine or reagent for preventing, diagnosing or treating aortic aneurysm
申请人: ZHONGSHAN HOSPITAL FUDAN UNIV
优先权: 2023
CN
Irreversible inhibitor of targeted FAP, molecular probe and application
申请人: BEIJING INSTITUTE FOR CANCER RES
优先权: 2023
CN
Targeted FAP trimer compound, probe, and preparation method and application thereof
申请人: CHINESE PLA ARMY SPECIALIZED MEDICAL CT
优先权: 2026
CN
FAP INHIBITOR, FAP-TARGETED NUCLIDE PROBE. AND APPLICATION THEREOF
申请人: SHANGHAI INST MATERIA MEDICA CAS
优先权: 2023
CN
WO
2 件公开
一种FAP抑制剂和靶向FAP的核素探针及应用
申请人: 首都医科大学附属北京朝阳医院
优先权: 2022
CN
药物
反馈